medigraphic.com
ISSN 2448-8747 (Print)
Publicación cuatrimestral editada por la Secretaría de Salud Jalisco

2022, Number 3

<< Back Next >>

Sal Jal 2022; 9 (3)

Enfermedad por arañazo de gato ¿Porque solo Jalisco reporta la mayoría de los casos? Parte 2

Martinez-Arce P, Reyes-Gómez U, Aquino-Villagómez DN, Reyes-Hernández KL, Reyes-Hernández MU, Espinosa-Sotero C, Hernández-Magaña R, Sánchez-Navarro LM, Echeverria-Mayrén C, Guerrero-Becerra M, Matos-Alviso LJ, Pérez-Pacheco O, Cuevas-López LL, Reyes-Cruz MA

Language: Spanish
References: 32
Page: 182-188
PDF size: 207.38 Kb.


ABSTRACT

Cat-scratch disease in Mexico is poorly diagnosed, this second part talks about complementary paraclinical methods to support its diagnosis and diff erential pathologies especially in the etiology of adenopathies. It is complemented with the current treatment of the disease considering azithromycin with the drug of choice. Th eir prognosis and primary preventive care measures are reviewed, which mainly includes those who have felids as pets receive a comprehensive management that includes management of the fl eas that infect this bartonellosis, and that children are educated in the sense of respecting your pets by not considering them as toys or gift s, and avoiding contact with stray cats. Finally, it is analyzed because the State of Jalisco reports most of the cases, it is concluded that the clinical knowledge of a Pediatric Hospital of these has increased its detection.


REFERENCES

  1. Nelson CA, Moore AR, Perea AE, Mead PS. Enfermedad porarañazo de gato: experiencia y conocimiento de los médicos de EE.UU. Zoonosis Salud Pública. 2018 Feb; 65 (1): 67-73. [ PubMed ]

  2. Chondrogiannis K, Vezakis A, Derpapas M, Melemeni A,Fragulidis G. Seronegative cat-scratch disease diagnosed by PCRdetection of Bartonella henselae DNA in lymph node samples.Brazilian Journal of Infectious Diseases 2012; 16(1):

  3. Donovan TA, Balakrishnan N, Carvalho BI, McCoy T,Breitschwerdt EB, Foax PR. Bartonella spp. as a Possible Cause orCofactor of Feline Endomyocarditis-Left Ventricular EndocardialJ Comp Pathol. 2018;162: 29-42.

  4. Erdem G, Watson RJ, Garret HW, Young C, Tomatis SC, JonathanR. et. al. Clinical and radiologic manifestations of bone infectionin children with cat scratch disease J Pediatr 2018; 20(1): 274-80

  5. Bances GM, Landa GL, Amoreti M, Candela HJ. Detecciónecográfi ca de lesiones hepatoesplenicas en niños con Enfermedadpor arañazo de gato. Rev Peruana Radiol 2011; 15(1): 32-6

  6. Inmaculada P, Sanfeliu I, Nogueras MM, Sala M, Cervantes M,Amengual J, Segura F. Seroprevalence of Bartonella spp infectionin HIV patients in Catalonia Spain BMC Infect Dis. 2008; 8: 58.

  7. Baptista M, Lo D, Hein N, Hires M, Miyao C, Betta S et al. Catscratchdisease presenting as multiple hepatic lesions: case reportand literature review. Autopsy Case Report. 2014; 4(2): 43-48.

  8. Olasoal MC, García GM, García GG, Giachetto LM, GutierrezB, Pirez G. Enfermedad por arañazo de gato: característicasclínicas en niños hospitalizados Cat scratch disease: Clinicalcharacteristics in hospitalized children. Anales de Pediatría2011; 74(1): 42-6

  9. Shasha D, Gilon D, Vermea F, Moses EA, Strhilevitz J. VisceralCat Scratch Disease With Endocarditis in an ImmunocompetentAdult: A Case Report and Review of the Literatur VectorBorne Zoonotic Di 2014; 14(3): 175-81. doi: 10.1089/vbz.2012.1279. Epub 2014 Feb 27.

  10. Gallois Y, Cogo H, Debuisson C, Guet-Revillet H, Brehin C, BaladiB. Et al.Nontuberculous lymphadenitis in children: Whatmanagement strategy? Int J Pediatr Otorhinolaryngol. 2019; 122:196-202.

  11. Cedeño CH, Sánchez DM, Salcedo VI, Mena CC. Reporte de casoclínico: enfermedad por arañazo de gato en paciente Pediátrico.Rev. Med. FCM-UCSG, 2014; 18(4): 71-4

  12. Reyes CA. Linfadenopatía Cervical, Criterios clínicos. ActaPediatr Mex. 2017; 38(3): 208-14

  13. Barnafi N, Conca N, Von Borries C, Fuentes I, Montoya F, AlcaldeE. Infección por Bartonella henselae con compromiso de sistemanervioso central, asociado a un papiloma del plexo coroídeo RevChilena Infecto 2017; 34 (4): 383-8

  14. Karski J, Matuszewski L, Okonski M, Pietrzyk D, Karska K.Cat Scratch Disease in a 1.5-year-old girl - Case report. Ann AgricEnviron Med. 2018; 25(2): 345-8.

  15. Matias SF, Xochihua DL, Reyes HK, Reyes GU, Miranda GD,Guerrero BM y cols. Abordaje del niño con fi ebre prolongada.Bol Clin Hosp Inf Edo Son 2020; 37(1): 15-22

  16. Somoza MM. Fiebre prolongada y fi ebre de origen desconocido,Act Pediat Aten Prim. 2012; 5(3): 144-8.

  17. Prutsky G, Domecq JP, Mori L, BBC S, Matzumura M, Sabouni A,Shahrour A, Erwin PJ, Boyce TG, Montori VM, Malaga G, MuradMH. Treatment outcomes of human bartonellosis: a systematicreview and meta-analysis. Int. J. Infect. Dis. 2013; 17(10): 811-9.

  18. Gallagher CJ, MacCougall C. Antibiotics simplifi ed fourthedition University of Callifornia USA: Jones Bartlett Learning;2018.p.106-8.

  19. Pennisi MG, Marsilio F, Hartmann K, Lloret A, Addie D, Belák S.Et. Al Bartonella species infection in cats: ABCD guidelines onprevention and management. J. Feline Med. Surg. 2013;15(7): 563-9.

  20. Shorbatli LA, Korany KI, Nahata MC. Eff ectiveness of antibiotictherapy in pediatric patients with cat scratch disease. Int J ClinPharm. 2018; 40(6):1458-61

  21. Phan A, Castagnini L. Corticosteroid treatment for prolongedfever in hepatosplenic cat-scratch disease: a case study. ClinicalPediatrics. 2017; 56(14):1291-2

  22. Maiques TE, Tomates SC, Watson J, Ramilo O, Media A.Enfermedad diseminada por arañazo de gato: en amplio espectrode la presentación Anales de Pediatría 2019; 90(6): 393-5

  23. Florin TA, Zaoutis TE, Zaoutis LB. Beyond cat scratch disease:Widening spectrum of Bartonella henselae infection. Pediatrics2008; 121: 1413-25

  24. Helan JVG, Grinberg A, Gedye K, Potter MA, Harrus S. Moleculardetection of Bartonella coopersplainsensis and B. henselae in ratsfrom New Zealand. N Z Vet J. 2018; 66(5): 257-60

  25. Vierira DG, Paolo VP, Urso LH, Sowy S,Gerardi SD, GrosselliB. Et al. Bartonella clarridgeiae Bacteremia Detected in anAsymptomatic Blood DonorJournal of Clinical Micrbiology 2010; 43: 2651–5.

  26. Barros S, de Andrade GC, Cavalcanti C, Nascimento H. CatScratch Disease: Not a Benign Condition. Ocul. Immunol.Infl amm. 2018;26(7):1115-22.

  27. Prutsky G, Domecq JP, Mori L, Bebko S, Matzumura M, SabouniA. Et al. Treatment outcomes of human bartonellosis: a systematicreview and meta-analysis. Int. J. Infect. Dis. 2013; 17(10): 811-9.

  28. Bush ML, Pérez TM. Last full review/revision 2018

  29. Bass JW, Freitas BC, Freitas AD, Sisler CL, et al. Prospectiverandomized double blind placebo-controlled evaluation ofazithromycin for treatment of cat-scratch disease. Pediatric InfectDis J 1998; 17: 447-5

  30. Ives TJ, Manzewitsch P, Regnery RL, et al. In vitro susceptibilitiesof Bartonella henselae, B. quintana, B. elizabethae,Rickettsia rickettsii, R. conorii, R. akari and R. prowazekii tomacrolide antibiotics as determined by immunofl uorescentantibody analysis of infected vero cell monolayers. Antimi- crobAgents Chemother 1997; 41: 578-82.

  31. Rolain JM, Brouqui P, Koehler JE, et al. Recommendations fortreatment of human infections caused by Bartonella species.Antimicrob Agents Chemother 2004; 48: 1921-33.

  32. Margileth AM. Recent advances in diagnosis and treatment of catscratch disease. Curr Infect Dis Rep 2000; 2: 141-6.




2020     |     www.medigraphic.com